Sopharma issued the following announcement on June 5.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for May 2019 the Company recorded an increase in sales of 22% compared to the same month of 2018, incl. 1% increase in sales for the domestic market and 36% growth in export sales.
In the first five months of 2019 the revenues from sales of production increased by 1% compared to the same period of 2018, incl. 13% decrease in domestic sales and 11% increase of export sales.
Original source can be found here.
